CLINICAL_TRIALS
trial_result
· 2021-05-25
Clinical Trial Update: Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced Breast Cancer [Phase 2]
Summary
Phase 2 rollover study of weekly paclitaxel (BMS-181339) in advanced breast cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-05-25